196 related articles for article (PubMed ID: 36908025)
1. Circ_0078607 increases platinum drug sensitivity via miR-196b-5p/GAS7 axis in ovarian cancer.
Dai C; Dai SY; Gao Y; Yan T; Zhou QY; Liu SJ; Liu X; Deng DN; Wang DH; Qin QF; Zi D
Epigenetics; 2023 Dec; 18(1):2175565. PubMed ID: 36908025
[TBL] [Abstract][Full Text] [Related]
2. Circ_0007841 knockdown confers cisplatin sensitivity to ovarian cancer cells by down-regulation of NFIB expression in a miR-532-5p-dependent manner.
Gao Y; Huang Y
J Chemother; 2023 Apr; 35(2):117-130. PubMed ID: 35380509
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of circ-PIP5K1A overcomes resistance to cisplatin in ovarian cancer by miR-942-5p/NFIB axis.
Sheng H; Wang X
Anticancer Drugs; 2023 Feb; 34(2):214-226. PubMed ID: 36730637
[TBL] [Abstract][Full Text] [Related]
4. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
Cheng J; Zhang R; Yan M; Li Y
BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
[TBL] [Abstract][Full Text] [Related]
6. Circ_0026123 promotes cisplatin resistance and progression of ovarian cancer by upregulating RAB1A through sequestering miR-543.
Wei L; He W; Zhao H; Zhao P
Anticancer Drugs; 2022 Nov; 33(10):1069-1080. PubMed ID: 36255068
[TBL] [Abstract][Full Text] [Related]
7. Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR-379-5p.
Wang L; Wang D; Xu Z; Qiu Y; Chen G; Tan F
Thorac Cancer; 2023 Jul; 14(20):1946-1957. PubMed ID: 37277864
[TBL] [Abstract][Full Text] [Related]
8. Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lung cancer.
Chang F; Li J; Sun Q; Wei S; Song Y
Bioengineered; 2022 Apr; 13(4):8806-8822. PubMed ID: 35287543
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA circ_0005667 promotes cisplatin resistance of endometrial carcinoma cells by regulating IGF2BP1 through miR-145-5p.
Sun G; Tian J; Xiao Y; Zeng Y
Anticancer Drugs; 2023 Aug; 34(7):816-826. PubMed ID: 36728962
[TBL] [Abstract][Full Text] [Related]
10. Circ_0048856 competes with ABCC1 for miR-193a-5p/miR-98-5p binding sites to promote the cisplatin resistance and tumorigenesis in lung cancer.
Liu L; Zhang Q; Peng H
J Chemother; 2023 Feb; 35(1):39-52. PubMed ID: 35289739
[TBL] [Abstract][Full Text] [Related]
11. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells.
Yao W; Guo P; Mu Q; Wang Y
Cancer Biother Radiopharm; 2021 May; 36(4):347-359. PubMed ID: 32799541
[No Abstract] [Full Text] [Related]
12. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S
Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA PRMT5 knockdown enhances cisplatin sensitivity and immune response in non-small cell lung cancer by regulating miR-138-5p/MYH9 axis.
Xu Y; Zhao R; Wang H; Jiang J; Wang Z; Wang J; Zhang W; Li M
J BUON; 2021; 26(5):1850-1861. PubMed ID: 34761592
[TBL] [Abstract][Full Text] [Related]
14. Hsa_circ_0074269-mediated Upregulation of TUFT1 Through miR-485-5p Increases Cisplatin Resistance in Cervical Cancer.
Chen J; Wu S; Wang J; Sha Y; Ji Y
Reprod Sci; 2022 Aug; 29(8):2236-2250. PubMed ID: 35075616
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer.
Liu X; Yin Z; Wu Y; Zhan Q; Huang H; Fan J
Bioengineered; 2022 Feb; 13(2):3739-3750. PubMed ID: 35081867
[TBL] [Abstract][Full Text] [Related]
16. Circ_0110498 facilitates the cisplatin resistance of non-small cell lung cancer by mediating the miR-1287-5p/RBBP4 axis.
Hao D; Li Y; Shi J; Jiang J
Thorac Cancer; 2023 Mar; 14(7):662-672. PubMed ID: 36691322
[TBL] [Abstract][Full Text] [Related]
17. Circular RNAcirc_0076305 Promotes Cisplatin (DDP) Resistance of Non-Small Cell Lung Cancer Cells by Regulating
Wang X; Wang H; Jiang H; Qiao L; Guo C
Cancer Biother Radiopharm; 2023 Jun; 38(5):293-304. PubMed ID: 34339285
[No Abstract] [Full Text] [Related]
18. Hsa_circ_0007142 contributes to cisplatin resistance in esophageal squamous cell carcinoma via miR-494-3p/LASP1 axis.
Chang N; Ge N; Zhao Y; Yang L; Qin W; Cui Y
J Clin Lab Anal; 2022 May; 36(5):e24304. PubMed ID: 35312115
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of circ_CELSR1 facilitates paclitaxel resistance of ovarian cancer by regulating miR-149-5p/SIK2 axis.
Wei S; Qi L; Wang L
Anticancer Drugs; 2021 Jun; 32(5):496-507. PubMed ID: 33735118
[TBL] [Abstract][Full Text] [Related]
20. Circ_0109291 Promotes Cisplatin Resistance of Oral Squamous Cell Carcinoma by Sponging miR-188-3p to Increase
Gao F; Han J; Wang Y; Jia L; Luo W; Zeng Y
Cancer Biother Radiopharm; 2022 May; 37(4):233-245. PubMed ID: 32758011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
